Dr. Hua Chien Chen is the Founder and Chief Executive Officer of ACT Genomics co. ltd. In his role, Dr. Chen oversees the corporate management, operations as well as R&D programs for future application. Dr. Chen is also an accomplished scientist and acknowledged expert in the field of molecular biology, oncology and genomics. He previously served the National Health Research Institute as an Assistant Investigator to discover and develop molecular targets for new drugs in 1998. Dr. Chen later joined TaiGen Biotechnology as the Biology Director and was in charge of the company’s drug screening program. From 2006 to 2014, Dr. Chen took up a position as Associate Professor at Chang Gung University where he established a multiplexed micro-RNA quantification platform for Chang Gung Molecular Medicine Research Center. This platform was developed for non-invasive biomarkers for cancer and other diseases. Dr. Hua Chien Chen has a great deal of experiences in biotech industry, technology-based project evaluation and license negotiation.
Dr. Hua Chien Chen earned his Ph.D. in Biochemistry from National Yang-Ming University in Taiwan and completed a postdoctoral training in Molecular Biology at Case Western Reserve University in the US.